Heart Disease Trial, Recruiting NCT06055504 Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER) Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06055504
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older at the time of screening.
  • You have already been diagnosed with a type of heart condition called non-ischemic dilated cardiomyopathy (a weakened, enlarged heart not caused by blocked arteries).
  • You have been on the best possible heart medications at the highest doses you can tolerate for at least 3 months before screening.
  • Your heart condition causes mild to moderate symptoms, such as shortness of breath or fatigue during everyday activities (confirm with trial site).
  • A special heart scan (called a cardiac MRI) shows that your heart is pumping at 35% or less of its normal capacity.
  • You are expected to live for more than 12 months.

Who may not be able to join:

  • You have a history of blocked or narrowed heart arteries that could explain your weak heart, including previous procedures to open arteries or significant blockages found on a heart scan.
  • Your weak heart is thought to be caused by a heart defect you were born with, a problem with your heart valves, heavy alcohol use, or chemotherapy treatment.
  • You have been diagnosed with a thickened or abnormally filled heart muscle, active inflammation of the heart, or scarring around the heart.
  • You have previously survived a sudden cardiac arrest or had a serious abnormal heart rhythm called sustained ventricular tachycardia.
  • Your heart condition causes severe symptoms even at rest or with the slightest activity (confirm with trial site).
  • You are currently on an emergency waiting list for a heart transplant.
  • You have previously received a transplanted organ such as a lung, liver, heart, or kidney.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pablo García Pavía, H.U. Puerta de Hierro, Majadahonda

Phone: +34911916749

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Registry
ClinicalTrials.gov
Start date
6 September 2023
Est. completion
1 October 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Composite end-point of all cause death, hospitalization due to device-related complications, and non-fatal major arrhythmic events.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov